Novo Owner’s CEO on Obesity Sales Boom, Catalent Deal
March 12, 2024
3,558
42
2
1.24%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg Television Episodes Around March 12, 2024
See what was published immediately before and after this episode.
8:27Now PlayingNovo Owner’s CEO on Obesity Sales Boom, Catalent Deal
YouTube Description
as posted by the channelNovo Holdings CEO Kasim Kutay discusses the surge in income from obesity drug sales and offers an update on the Catalent deal and insight on the company’s deal strategy.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.